The United States Food and Drug Administration (FDA) has issued an alert regarding certain medications, specifically Valsartan and Valsartan/HCTZ, which are commonly prescribed for controlling blood pressure.
An impurity known as NMDA has been detected in some of these products, which may potentially pose a cancer risk. As a result, the FDA has recommended a recall of the affected drugs.
If you are currently taking this medication, please don’t be alarmed. We have a system in place to address this matter swiftly. Contact us as soon as possible, and we will assist you in switching to an alternative medication.
.svg)
